Developing a Colonoscopy Preparation Protocol for Patients With Diabetes

NCT07526103 — Not applicable, Not yet recruiting, 40 participants, Queen's University

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  
RegistryNCT07526103
StatusNot yet recruiting
PhaseNot applicable
Study typeInterventional; randomized, parallel, masking: single, prevention
Enrollment40 (Estimated)
SponsorQueen's University (Other)
ConditionsHypoglycaemia, Diabete Mellitus, Colonoscopy (Ambulatory Patients)
Interventionstiming of cleansing and procedure (Other)
Datesstart 2026-06-01 (estimated), primary completion 2028-06-01 (estimated), completion 2028-06-01 (estimated), first posted 2026-04-13, last updated 2026-04-24
Locations1 site in Canada

Related Papers Related Patents Related Grants Related Experts
All trials for Hypoglycaemia All trials for Diabete Mellitus All trials of timing of cleansing and procedure

-Summary

Patients with diabetes have less effective colonoscopy preparation when compared to nondiabetic patients. This leads to the possibility of missed polyps, longer procedural time and patient dissatisfaction. Furthermore, the peri-colonoscopy period has been associated with increased risk of hypoglycemic events given the required change in diet and possible changes in antihyperglycemic medication regime, though this area is not well studied.

Studies have found that same day preparation for colonoscopy allowed for comparable bowel visualization to split dosing. Pairing this with a low fiber diet permitted the day prior to colonoscopy, the extent of changes to routine and diet within a patient with diabetes day for colonoscopy preparation is minimized and could reduce risk of side effects and hypoglycemia, while also ensuring adequate bowel preparation.

This study tests the hypothesis that creating a diabetic specific protocol (permitting a low fibre diet the day prior to colonoscopy and using same day preparation) will result in fewer hypoglycemic events and more adequate quality preparation in comparison to a conventional 2L PEG split day preparation with dietary restrictions in patients with diabetes.

Expand all sections  ·  Collapse all

+Arms and interventions

ArmTypeInterventionsDescription
Control Group (Standard Preparation)Active comparatorOther: timing of cleansing and procedureParticipants will follow a clear-liquid diet after breakfast on the day before colonoscopy. They will ingest 2L of PEG at 7:00 PM the evening before the procedure and the remaining 2L four hours prior to colonoscopy.
Diabetes-Specific Protocol GroupExperimentalOther: timing of cleansing and procedureParticipants will follow a four-day, low-fiber carbohydrate diet. They will be allowed to consume dinner up until 7:00 PM the night before the colonoscopy. On the day of the procedure, they will ingest 2L of PEG between 5:00 AM and 6:00 AM and the remaining 2L between 8:00 AM and 9:00 AM.
  • timing of cleansing and procedure (Other): we are altering the timing of colonoscopy and cleansing for colonoscopy for patients with diabetes.

+Outcome measures

Primary outcomes

  • Bowel Preparation [During colonoscopy]: Primary outcome is the proportion of patients achieving an adequate bowel preparation, defined as a Boston bowel preparation scale (BBPS) score of 6 or greater, with no section scoring below 2 . The scale ranges from 0-9, with 9 being the best possible score.

Secondary outcomes

  • Glucose Monitoring [Pericolonoscopy period]: Evaluating the incidence of hypoglycemic events (blood glucose <3.9 mmol/L) from the initiation of bowel preparation until discharge from colonoscopy suite.
  • Patient Rating [Pericolonoscopy period]: Patient-reported ratings of convenience, tolerability and adverse events associated with the preparation protocol.

+Eligibility

Sex: All, ages: 18 Years to 75 Years

Inclusion Criteria:

1. Patients Age over the age of 18
2. Able to read and understand the English language
3. Confirmed diagnosis of diabetes (Type 1 or Type 2)

Exclusion Criteria:

1. Patients without diabetes
2. Patients with prior hospital admission due to hypoglycemic events
3. Patients who have inflammatory bowel disease
4. Patients with ileus or bowel obstruction
5. Patients with history of colorectal resection
6. Patients receiving combined upper and lower endoscopies
7. Patients with ascites
8. Patients with previously documented severe renal impairment
9. Unable to provide consent
10. Pregnant or lactating female (females of child-bearing potential will undergo urine pregnancy testing)
11. Patients who have had a recent myocardial infarction(<6months)
12. Allergy to product ingredients

+Locations (1)

FacilityCityCountryStatus
Kingston Health Sciences CentreKingston, OntarioCanada

+Publications

  • Tong Y, Huang JQ, Chen Y, Tu M, Wang W. Impact of glucagon-like peptide 1 receptor agonist liraglutide and dipeptidyl peptidase-4 inhibitor sitagliptin on bowel cleaning and gastrointestinal symptoms in type 2 diabetes. Front Pharmacol. 2023 Apr 6;14:1176206. doi: 10.3389/fphar.2023.1176206. eCollection 2023. PMID 37089939
  • Alvarez-Gonzalez MA, Flores-Le Roux JA, Seoane A, Pedro-Botet J, Carot L, Fernandez-Clotet A, Raga A, Pantaleon MA, Barranco L, Bory F, Lorenzo-Zuniga V. Efficacy of a multifactorial strategy for bowel preparation in diabetic patients undergoing colonoscopy: a randomized trial. Endoscopy. 2016 Nov;48(11):1003-1009. doi: 10.1055/s-0042-111320. Epub 2016 Aug 4. PMID 27490086
  • Seo M, Gweon TG, Huh CW, Ji JS, Choi H. Comparison of Bowel Cleansing Efficacy, Safety, Bowel Movement Kinetics, and Patient Tolerability of Same-Day and Split-Dose Bowel Preparation Using 4 L of Polyethylene Glycol: A Prospective Randomized Study. Dis Colon Rectum. 2019 Dec;62(12):1518-1527. doi: 10.1097/DCR.0000000000001499. PMID 31567921
  • International Hypoglycaemia Study Group. Hypoglycaemia, cardiovascular disease, and mortality in diabetes: epidemiology, pathogenesis, and management. Lancet Diabetes Endocrinol. 2019 May;7(5):385-396. doi: 10.1016/S2213-8587(18)30315-2. Epub 2019 Mar 27. PMID 30926258
  • Chirila A, Nguyen ME, Tinmouth J, Halperin IJ. Preparing for Colonoscopy in People with Diabetes: A Review with Suggestions for Clinical Practice. J Can Assoc Gastroenterol. 2022 Dec 30;6(1):26-36. doi: 10.1093/jcag/gwac035. eCollection 2023 Feb. PMID 36789141
  • Gandhi K, Tofani C, Sokach C, Patel D, Kastenberg D, Daskalakis C. Patient Characteristics Associated With Quality of Colonoscopy Preparation: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2018 Mar;16(3):357-369.e10. doi: 10.1016/j.cgh.2017.08.016. Epub 2017 Aug 18. PMID 28826680
  • Chung YW, Han DS, Park KH, Kim KO, Park CH, Hahn T, Yoo KS, Park SH, Kim JH, Park CK. Patient factors predictive of inadequate bowel preparation using polyethylene glycol: a prospective study in Korea. J Clin Gastroenterol. 2009 May-Jun;43(5):448-52. doi: 10.1097/MCG.0b013e3181662442. PMID 18978506
  • Taylor C, Schubert ML. Decreased efficacy of polyethylene glycol lavage solution (golytely) in the preparation of diabetic patients for outpatient colonoscopy: a prospective and blinded study. Am J Gastroenterol. 2001 Mar;96(3):710-4. doi: 10.1111/j.1572-0241.2001.03610.x. PMID 11280539
  • Nguyen DL, Jamal MM, Nguyen ET, Puli SR, Bechtold ML. Low-residue versus clear liquid diet before colonoscopy: a meta-analysis of randomized, controlled trials. Gastrointest Endosc. 2016 Mar;83(3):499-507.e1. doi: 10.1016/j.gie.2015.09.045. Epub 2015 Oct 13. PMID 26460222